Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NITE Nightstar Therapeutics Plc ADS

0.00 (0.00%)
Apr 11 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 18.50
Ask Price 25.41
News -
Company Name Stock Ticker Symbol Market Type
Nightstar Therapeutics Plc ADS NITE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 25.41 20:00:00
Open Price Low Price High Price Close Price Prev Close
25.41 25.41
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 25.41 USD

Nightstar Therapeutics Plc ADS Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 852.16M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Nightstar Therapeutics Plc ADS News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NITE Message Board. Create One! See More Posts on NITE Message Board See More Message Board Posts

Historical NITE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Nightstar Therapeutics Plc ADS Description

Nightstar Therapeutics PLC is a clinical-stage gene therapy company. It is focused on developing and commercializing a pipeline of novel and potentially curative, one-time retinal gene therapies for patients suffering from rare inherited retinal diseases. The company's retinal gene therapy product candidate, NSR-REP1, is being developed for the treatment of choroideremia, a rare, degenerative, X-linked genetic retinal disorder primarily affecting males that are caused by a mutation in the CHM gene.

Your Recent History

Delayed Upgrade Clock